Edition:
United Kingdom

Regenxbio Inc (RGNX.OQ)

RGNX.OQ on NASDAQ Stock Exchange Global Select Market

29.25USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$29.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
93,285
52-wk High
$35.95
52-wk Low
$16.30

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.34 -0.669
Jun '17 6.56 -0.472
Mar '17 0.46 -0.825
FY 2016 Dec '16 1.70 -0.741
Sep '16 0.12 -0.686
Jun '16 2.38 -0.548
Mar '16 0.39 -0.409
FY 2015 Dec '15 4.44 -0.197
Sep '15 1.14 -0.289
Jun '15 1.36 -0.347
Mar '15 0.64 -0.128
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 0.55 1.20 0.00 2.00
Quarter Ending Mar-18 3 1.07 2.00 0.00 2.00
Year Ending Dec-17 4 8.82 15.07 1.80 7.89
Year Ending Dec-18 5 8.50 23.30 0.00 9.17
Earnings (per share)
Quarter Ending Dec-17 4 -0.79 -0.67 -0.92 -0.53
Quarter Ending Mar-18 3 -0.76 -0.69 -0.88 -0.62
Year Ending Dec-17 5 -2.72 -2.43 -2.87 -2.68
Year Ending Dec-18 6 -3.08 -2.73 -3.51 -2.43
LT Growth Rate (%) 1 -7.10 -7.10 -7.10 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.77 45.62
P/E Low - Last 5 Yrs. -- 93.67 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) 117.63 100.68 5.40
Price to Book (MRQ) 4.90 13.50 5.38
Price to Tangible Book (MRQ) 4.91 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions 74.23 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 176.29 433.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago 5.77 75.04 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 13.81 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -90.63 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 14.47 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.93 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -- -111.94 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 79.94 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -852.14 -- --
EBITD - 5 Yr. Avg -- -261.13 15.24
Operating Margin (TTM) -872.54 -556.69 7.76
Operating Margin - 5 Yr. Avg. -- -279.31 10.75
Pre-Tax Margin (TTM) -844.80 -529.93 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.05 11.17
Net Profit Margin (TTM) -839.87 -531.37 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.22 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 82,598 25,316,769 864,680,848
Net Income/Employee (TTM) -693,720 3,332,346 101,718,394
Receivable Turnover (TTM) 21.22 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.04 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -34.49 -0.77 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -36.22 2.36 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -36.40 2.96 16.05
Return on Equity - 5 Yr. Avg. -- 6.41 17.51
  1 Year 3 Year 5 Year
Sales % -39.52 -8.99 --
EPS (TTM) % -146.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Regenxbio Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 30.93 26.42 91 53
13 Week 66.17 58.08 95 60
26 Week 98.53 83.43 94 69
52 Week 119.08 85.68 90 46
YTD 81.40 59.31 85 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 69.75%
# of Holders: 146
Total Shares Held: 21,724,295
3 Mo. Net Change: -1,531,326
# New Positions: 30
# Closed Positions: 23
# Increased Positions: 80
# Reduced Positions: 51
# Net Buyers: 29
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.